ATE266725T1 - Für den typ ii-morphogenetischen-knochenprotein- rezeptor kodierende cdns - Google Patents

Für den typ ii-morphogenetischen-knochenprotein- rezeptor kodierende cdns

Info

Publication number
ATE266725T1
ATE266725T1 AT95939661T AT95939661T ATE266725T1 AT E266725 T1 ATE266725 T1 AT E266725T1 AT 95939661 T AT95939661 T AT 95939661T AT 95939661 T AT95939661 T AT 95939661T AT E266725 T1 ATE266725 T1 AT E266725T1
Authority
AT
Austria
Prior art keywords
cdns
encoding
type
protein receptor
bone protein
Prior art date
Application number
AT95939661T
Other languages
English (en)
Inventor
Jan Susan Rosenbaum
Tsutomu Nohno
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23305967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE266725(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE266725T1 publication Critical patent/ATE266725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Dc Digital Transmission (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95939661T 1994-11-04 1995-10-30 Für den typ ii-morphogenetischen-knochenprotein- rezeptor kodierende cdns ATE266725T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/334,179 US6306622B1 (en) 1994-11-04 1994-11-04 cDNA encoding a BMP type II receptor
PCT/US1995/014085 WO1996014412A2 (en) 1994-11-04 1995-10-30 cDNA ENCODING A BMP TYPE II RECEPTOR

Publications (1)

Publication Number Publication Date
ATE266725T1 true ATE266725T1 (de) 2004-05-15

Family

ID=23305967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939661T ATE266725T1 (de) 1994-11-04 1995-10-30 Für den typ ii-morphogenetischen-knochenprotein- rezeptor kodierende cdns

Country Status (12)

Country Link
US (1) US6306622B1 (de)
EP (1) EP0804577B1 (de)
JP (1) JPH10509591A (de)
CN (1) CN1171816A (de)
AT (1) ATE266725T1 (de)
AU (1) AU710569B2 (de)
CA (1) CA2204151C (de)
DE (1) DE69533044T2 (de)
DK (1) DK0804577T3 (de)
FI (1) FI971896A7 (de)
NO (1) NO972063D0 (de)
WO (1) WO1996014412A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306622B1 (en) * 1994-11-04 2001-10-23 The Procter & Gamble Co. cDNA encoding a BMP type II receptor
WO1996018735A2 (en) * 1994-12-14 1996-06-20 Amgen Boulder Inc. Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp)
CA2229557A1 (en) * 1995-08-14 1997-02-27 Creative Biomolecules, Inc. Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
EP0981745A1 (de) * 1997-05-16 2000-03-01 The Procter & Gamble Company Die verwendung von bmp-protein-rezeptor komplexen zur auffindung von substanzen die zellulare differenzierung induzieren und zellen die mit einem activin-rezeptr co-transfiziert sind
AU2002218774A1 (en) * 2000-07-12 2002-01-21 The Trustees Of Columbia University In The City Of New York Role of pph1 gene in pulmonary hypertension
AU2002318168B2 (en) 2002-02-25 2007-12-13 Vaxiion Therapeutics, Llc Minicell compositions and methods
US20070036769A9 (en) * 2004-06-03 2007-02-15 Linheng Li BMP pathway methods and compositions
US8410246B2 (en) 2004-06-17 2013-04-02 Thrasos, Inc. TDF-related compounds and analogs thereof
CN100410384C (zh) * 2004-12-08 2008-08-13 上海第二医科大学附属第九人民医院 骨形成蛋白4基因的反转录病毒载体及其应用
WO2006130022A1 (en) * 2005-05-30 2006-12-07 Agresearch Limited Modulation of ovulation by agonists and antagonists of bmprii
DK2497780T3 (en) 2005-09-20 2015-06-01 Thrasos Innovation Inc TDF-related compounds and analogs thereof
US11361161B2 (en) 2018-10-22 2022-06-14 Verint Americas Inc. Automated system and method to prioritize language model and ontology expansion and pruning
CN112630439A (zh) * 2020-12-11 2021-04-09 郑州轻工业大学 基于纳米金的分裂型适体传感器及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
CA2002011A1 (en) 1988-11-14 1990-05-14 Anthony F. Purchio Normal human growth regulatory receptor for tgf-beta
EP0542971A1 (de) 1991-05-10 1993-05-26 The Salk Institute For Biological Studies Klonierung und rekombinantherstellung eines rezeptors oder von rezeptoren der aktivin/tgf-beta-superfamilie.
US5216126A (en) 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
AU671606B2 (en) 1991-10-31 1996-09-05 Whitehead Institute For Biomedical Research TGF-beta type receptor cDNAs and uses therefor
AU3920693A (en) * 1992-03-18 1993-10-21 General Hospital Corporation, The Four novel receptors of the TGF-beta receptor family
CA2149441C (en) 1992-11-17 2004-03-02 Kohei Miyazono Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
US6248554B1 (en) 1993-11-24 2001-06-19 The Procter & Gamble Company DNA sequence coding for a BMP receptor
US6210899B1 (en) * 1994-11-04 2001-04-03 The Procter & Gamble Company Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
US6306622B1 (en) * 1994-11-04 2001-10-23 The Procter & Gamble Co. cDNA encoding a BMP type II receptor

Also Published As

Publication number Publication date
DK0804577T3 (da) 2004-09-20
EP0804577A2 (de) 1997-11-05
JPH10509591A (ja) 1998-09-22
DE69533044T2 (de) 2006-02-09
CA2204151A1 (en) 1996-05-17
FI971896L (fi) 1997-07-02
FI971896A0 (fi) 1997-05-02
NO972063L (no) 1997-05-05
WO1996014412A3 (en) 1996-08-29
AU4139296A (en) 1996-05-31
FI971896A7 (fi) 1997-07-02
CA2204151C (en) 2002-09-17
WO1996014412A2 (en) 1996-05-17
US6306622B1 (en) 2001-10-23
DE69533044D1 (de) 2004-06-17
AU710569B2 (en) 1999-09-23
EP0804577B1 (de) 2004-05-12
CN1171816A (zh) 1998-01-28
NO972063D0 (no) 1997-05-05

Similar Documents

Publication Publication Date Title
DE69533044D1 (de) FÜR DEN TYP II-MORPHOGENETISCHEN-KNOCHENPROTEIN-REZEPTOR KODIERENDE cDNS
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE69738586D1 (de) Hohe expressionsrate von proteinen
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
ATE395927T1 (de) Polypeptide eines heparin-bindenden wachstumsfaktors (hbgf)
EP0821064A3 (de) Recombinanter Fructosyl Aminosäure-Oxidase
WO1996007739A3 (en) Interleukin-1 type 3 receptors
AR016436A1 (es) Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades
WO2000026245A3 (en) Human membrane transport proteins
CA2173102A1 (en) Dna sequence coding for a bmp receptor
DK0724637T3 (da) Kortikotropinfrigørende faktor2-receptorer
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DK1007559T3 (da) Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DK0935652T3 (da) Keratinocyt vækstfaktor-2 produkter
NO922421L (no) Collagenbindende protein, samt fremstilling derav
NO951315L (no) Ökt produksjon av utsondrede proteiner fra rekombinante eukaryote-celler
SG49993A1 (en) Fused dna sequence fused protein expressed from said fused dna sequence and method for expressing said fused protein
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
IL139272A0 (en) New peptide fragments for protein purification
WO1998056813A3 (en) Two human membrane-fusion proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties